http://bio2rdf.org/drugbank_resource:DB00263_DB01124_nanopub.RAv6mWz9Nhw2R4M4Ls15NCased0jDCIDk4IrTo-dvIOyc#head http://bio2rdf.org/drugbank_resource:DB00263_DB01124_nanopub.RAv6mWz9Nhw2R4M4Ls15NCased0jDCIDk4IrTo-dvIOyc http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00263_DB01124_nanopub.RAv6mWz9Nhw2R4M4Ls15NCased0jDCIDk4IrTo-dvIOyc#assertion http://bio2rdf.org/drugbank_resource:DB00263_DB01124_nanopub.RAv6mWz9Nhw2R4M4Ls15NCased0jDCIDk4IrTo-dvIOyc http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00263_DB01124_nanopub.RAv6mWz9Nhw2R4M4Ls15NCased0jDCIDk4IrTo-dvIOyc#provenance http://bio2rdf.org/drugbank_resource:DB00263_DB01124_nanopub.RAv6mWz9Nhw2R4M4Ls15NCased0jDCIDk4IrTo-dvIOyc http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00263_DB01124_nanopub.RAv6mWz9Nhw2R4M4Ls15NCased0jDCIDk4IrTo-dvIOyc#publicationInfo http://bio2rdf.org/drugbank_resource:DB00263_DB01124_nanopub.RAv6mWz9Nhw2R4M4Ls15NCased0jDCIDk4IrTo-dvIOyc http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00263_DB01124_nanopub.RAv6mWz9Nhw2R4M4Ls15NCased0jDCIDk4IrTo-dvIOyc#assertion http://bio2rdf.org/drugbank:DB00263 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00263_DB01124 http://bio2rdf.org/drugbank:DB01124 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00263_DB01124 http://bio2rdf.org/drugbank_resource:DB00263_DB01124 http://purl.org/dc/terms/identifier drugbank_resource:DB00263_DB01124 http://bio2rdf.org/drugbank_resource:DB00263_DB01124 http://purl.org/dc/terms/title DDI between Sulfisoxazole and Tolbutamide - Tolbutamide and Sulfisoxazole are strong CYP2C9 inhibitors and substrates. Decreased metabolism and clearance of both agents may occur during concomitant therapy. Consider alternate therpy or monitor for changes in the therapeutic and adverse effects of both agents if concomitant therapy is initiated, discontinued or dose(s) changed. http://bio2rdf.org/drugbank_resource:DB00263_DB01124 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00263_DB01124 http://www.w3.org/2000/01/rdf-schema#label DDI between Sulfisoxazole and Tolbutamide - Tolbutamide and Sulfisoxazole are strong CYP2C9 inhibitors and substrates. Decreased metabolism and clearance of both agents may occur during concomitant therapy. Consider alternate therpy or monitor for changes in the therapeutic and adverse effects of both agents if concomitant therapy is initiated, discontinued or dose(s) changed. [drugbank_resource:DB00263_DB01124] http://bio2rdf.org/drugbank_resource:DB00263_DB01124_nanopub.RAv6mWz9Nhw2R4M4Ls15NCased0jDCIDk4IrTo-dvIOyc#provenance http://bio2rdf.org/drugbank_resource:DB00263_DB01124_nanopub.RAv6mWz9Nhw2R4M4Ls15NCased0jDCIDk4IrTo-dvIOyc#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00263_DB01124_nanopub.RAv6mWz9Nhw2R4M4Ls15NCased0jDCIDk4IrTo-dvIOyc#publicationInfo http://bio2rdf.org/drugbank_resource:DB00263_DB01124_nanopub.RAv6mWz9Nhw2R4M4Ls15NCased0jDCIDk4IrTo-dvIOyc#signature.MCwCFBuAz-NBwmZO http://purl.org/nanopub/x/hasPublicKey MIIBtzCCASwGByqGSM44BAEwggEfAoGBAP1/U4EddRIpUt9KnC7s5Of2EbdSPO9EAMMeP4C2USZpRV1AIlH7WT2NWPq/xfW6MPbLm1Vs14E7gB00b/JmYLdrmVClpJ+f6AR7ECLCT7up1/63xhv4O1fnxqimFQ8E+4P208UewwI1VBNaFpEy9nXzrith1yrv8iIDGZ3RSAHHAhUAl2BQjxUjC8yykrmCouuEC/BYHPUCgYEA9+GghdabPd7LvKtcNrhXuXmUr7v6OuqC+VdMCz0HgmdRWVeOutRZT+ZxBxCBgLRJFnEj6EwoFhO3zwkyjMim4TwWeotUfI0o4KOuHiuzpnWRbqN/C/ohNWLx+2J6ASQ7zKTxvqhRkImog9/hWuWfBpKLZl6Ae1UlZAFMO/7PSSoDgYQAAoGAETGrDm8R3KfndKRj7ttr3jVhhstI6/2Ey0ER9F5kdx7Hrd6eolq7yWzPzf2H754tdZxICzxYcdawBbL2ZUzFjWwXTNUQC3+e6evKPJyNELubnZcA+8TxIIwicBnw3Ku6mSeI8SUVr5SBV1VeJoSu/ahldv562IdBR8IagmzuT3Y= http://bio2rdf.org/drugbank_resource:DB00263_DB01124_nanopub.RAv6mWz9Nhw2R4M4Ls15NCased0jDCIDk4IrTo-dvIOyc#signature.MCwCFBuAz-NBwmZO http://purl.org/nanopub/x/hasSignature MCwCFBuAz+NBwmZOkLRBJnncdHBcM415AhQ0eE9c9Wn9DW7xfQ6SyjYt5JQe1w== http://bio2rdf.org/drugbank_resource:DB00263_DB01124_nanopub.RAv6mWz9Nhw2R4M4Ls15NCased0jDCIDk4IrTo-dvIOyc#signature.MCwCFBuAz-NBwmZO http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00263_DB01124_nanopub.RAv6mWz9Nhw2R4M4Ls15NCased0jDCIDk4IrTo-dvIOyc http://purl.org/dc/terms/created 2018-03-30T11:12:36.794+02:00 http://bio2rdf.org/drugbank_resource:DB00263_DB01124_nanopub.RAv6mWz9Nhw2R4M4Ls15NCased0jDCIDk4IrTo-dvIOyc http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00263_DB01124_nanopub.RAv6mWz9Nhw2R4M4Ls15NCased0jDCIDk4IrTo-dvIOyc http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00263_DB01124_nanopub.RAv6mWz9Nhw2R4M4Ls15NCased0jDCIDk4IrTo-dvIOyc#signature.MCwCFBuAz-NBwmZO http://bio2rdf.org/drugbank_resource:DB00263_DB01124_nanopub.RAv6mWz9Nhw2R4M4Ls15NCased0jDCIDk4IrTo-dvIOyc http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234